Efficacy and Safety of RBCs Derived From Mirasol-treated Whole Blood in Patients Requiring Chronic Transfusion (PRAISE)
Clinical trial NCT03329404 · TERMINATED
Trial details
- NCT number
- NCT03329404
- Sponsor
- Terumo BCTbio
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-12
- Primary completion
- 2018-12-19
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.